Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Bharat Immunologicals And Biologicals Corporation Limited, is an unlisted public company incorporated on 10 March, 1989. It is classified as a Government of India company and is located in Uttar Pradesh, Uttar Pradesh. It's authorized share capital is INR 51.00 cr and the total paid-up capital is INR 43.18 cr.
The current status of Bharat Immunologicals And Biologicals Corporation Limited is - Active.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Yogendra Kumar Gupta | 03432845 | 15 years |
Director | Mohd Aslam | 06786302 | 9 years |
Director | Pankaj Kumar | 07606566 | 3 years |
Director | Sudhanshu Vrati | 07673777 | 9 years |
Director | Alka Sharma | 07686722 | 9 years |
Director | Madhu Dikshit | 08495360 | 6 years |
Director | Dhananjay Kumar Tiwary | 10378609 | 2 years |
Kmp | Sandip Kumar Lal | <HIDDEN> | 18 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Canara Bank
No. of Loans: 1
Total Amount : 133.0 cr
IDBI Bank Limited
No. of Loans: 2
Total Amount : 10.1 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 0.9 cr
State Bank of India
No. of Loans: 1
Total Amount : 0.8 cr
State Bank of Hyderabad
No. of Loans: 1
Total Amount : 0.6 cr
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
FOUNDATION FOR DISEASE ELIMINATION AND CONTROL OF INDIA |
Active
|
1.0 L | 1 | Maharashtra |
SICUREMI HEALTHCARE TECHNOLOGIES PRIVATE LIMITED |
Active
|
49.8 L | 1 | Uttar Pradesh |
VATYKA HEALTH VISION LLP |
Active
|
10,000.0 | 1 | Uttar Pradesh |
CLIANTHA RESEARCH LIMITED |
Active
|
3.8 Cr | 1 | Gujarat |
INDIAN VACCINES CORPORATION LIMITED |
Active
|
18.8 Cr | 2 | Haryana |
NATIONAL DIVYANGJAN FINANCE AND DEVELOPMENT CORPORATION |
Active
|
400.0 Cr | 1 | Delhi |
NATIONAL HANDICAPPED FINANCE AND DEVELOPMENT CORPORATION (U/S.25) |
Active
|
400.0 Cr | 1 | Haryana |
INDIA PESTICIDES LIMITED. |
Active
|
11.5 Cr | 1 | Uttar Pradesh |
Read more
The incorporation date of BHARAT IMMUNOLOGICALS AND BIOLOGICALS CORPORATION LIMITED is 10 March, 1989
The authorized share capital of BHARAT IMMUNOLOGICALS AND BIOLOGICALS CORPORATION LIMITED is INR ₹ 51.0 Cr.
The paid-up capital of BHARAT IMMUNOLOGICALS AND BIOLOGICALS CORPORATION LIMITED is INR ₹ 43.2 Cr.
The registered address of BHARAT IMMUNOLOGICALS AND BIOLOGICALS CORPORATION LIMITED is VILLAAGE CHOLAPS-KOTOALI DEHAT BULANDSAHAR UTTAR PRADESH Uttar Pradesh - 203203
The CIN number of BHARAT IMMUNOLOGICALS AND BIOLOGICALS CORPORATION LIMITED is L24232UP1989GOI010542.